Literature DB >> 9809999

Accurate and objective preoperative diagnosis of thyroid papillary carcinomas by reverse transcription-PCR detection of oncofetal fibronectin messenger RNA in fine-needle aspiration biopsies.

T Takano1, A Miyauchi, T Yokozawa, F Matsuzuka, G Liu, T Higashiyama, S Morita, K Kuma, N Amino.   

Abstract

Recently, the restricted expression of oncofetal fibronectin mRNA was reported in thyroid papillary and anaplastic carcinomas. In this study, by extracting RNA from the leftover cells inside the needles used for fine-needle aspiration biopsy, we establish a new method for gene diagnosis of these carcinomas without further invasiveness to the patient (aspiration biopsy-reverse transcription-PCR, ABRP). RNA was extracted from 177 fine-needle aspiration biopsies of thyroid nodules that were suspicious for malignancy, and then the gene diagnoses made by reverse transciption-PCR detection of oncofetal fibronectin mRNA were compared with cytological diagnoses. Thirty-five (94.6%) of 37 samples that were diagnosed as papillary or anaplastic carcinomas by cytological examination showed a positive result by gene diagnosis, whereas only 4 (3.7%) of 109 samples that were cytologically diagnosed negative for both carcinomas showed a positive result. Among all of the cases, 50 patients underwent surgery, and a histological diagnosis was consequently made. The sensitivity and specificity of this method were 96.9 and 100%, respectively. A combined examination using both genetic and cytological approaches may contribute to a more precise preoperative diagnosis of papillary and anaplastic carcinomas.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9809999

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Microarray analysis of thyroid nodule fine-needle aspirates accurately classifies benign and malignant lesions.

Authors:  Carrie C Lubitz; Stacy K Ugras; J Jacob Kazam; Biaxin Zhu; Theresa Scognamiglio; Yao-Tseng Chen; Thomas J Fahey
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

Review 2.  Molecular diagnostic tests in the diagnosis and management of thyroid carcinoma.

Authors:  M D Ringel
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

3.  Evaluation of Endocrine Neoplasms Using Fine Needle Aspiration Biopsy.

Authors:  Mary E. Barcus; Celeste N. Powers
Journal:  Endocr Pathol       Date:  2000       Impact factor: 4.056

4.  ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours.

Authors:  S Karger; K Krause; M Gutknecht; K Schierle; D Graf; F Steinert; H Dralle; D Führer
Journal:  Br J Cancer       Date:  2012-01-05       Impact factor: 7.640

5.  Gene expression profiles in thyroid carcinomas.

Authors:  T Takano; Y Hasegawa; F Matsuzuka; A Miyauchi; H Yoshida; T Higashiyama; K Kuma; N Amino
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

6.  Recurrence of Papillary Thyroid Cancer: A Systematic Appraisal of Risk Factors.

Authors:  Hannah R Nieto; Caitlin E M Thornton; Katie Brookes; Albert Nobre de Menezes; Alice Fletcher; Mohammed Alshahrani; Merve Kocbiyik; Neil Sharma; Kristien Boelaert; Jean-Baptiste Cazier; Hisham Mehanna; Vicki E Smith; Martin L Read; Christopher J McCabe
Journal:  J Clin Endocrinol Metab       Date:  2022-04-19       Impact factor: 6.134

7.  High-throughput differential screening of mRNAs by serial analysis of gene expression: decreased expression of trefoil factor 3 mRNA in thyroid follicular carcinomas.

Authors:  T Takano; A Miyauchi; H Yoshida; K Kuma; N Amino
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.